Notice of Amended Preliminary Determination of Sales at Less Than Fair Value: Glycine From India, 62826-62827 [E7-21872]
Download as PDF
<![CDATA[
62826
Federal Register / Vol. 72, No. 215 / Wednesday, November 7, 2007 / Notices
Cash Deposit Requirements
The following deposit requirements
will be effective upon publication of the
final results of this administrative
review for all shipments of wire rod
from Trinidad and Tobago, entered or
withdrawn from warehouse, for
consumption on or after the publication
date of these final results, as provided
by section 751(a) of the Act: (1) For
Mittal no cash deposit will be required;
(2) for merchandise exported by
producers or exporters not covered in
this review, but covered in the lessthan-fair-value (LTFV) investigation or a
previous review, the cash deposit rate
will continue to be the most recent
company-specific rate established in the
final determination or final results; (3)
if the exporter is not a firm covered in
this review, a previous review, or the
LTFV investigation, but the producer is,
the cash deposit rate will be the rate
established for the producer of the
subject merchandise for the most recent
period; and (4) if neither the exporter
nor the producer is a firm covered in
this review, a previous review, or the
LTFV investigation, the cash deposit
rate will be 11.40 percent, the ‘‘All
Others’’ rate established in the
investigation. See Notice of Final
Determination of Sales at Less Than
Fair Value: Carbon and Certain Alloy
Steel Wire Rod From Trinidad and
Tobago, 67 FR 55788 (August 30, 2002).
These deposit requirements shall
remain in effect until further notice.
Reimbursement of Duties
This notice also serves as a final
reminder to importers of their
responsibility under 19 CFR
351.402(f)(2) to file a certificate
regarding the reimbursement of
antidumping duties prior to liquidation
of the relevant entries during this
review period. Failure to comply with
this requirement could result in the
presumption that reimbursement of
antidumping duties occurred and the
subsequent increase in antidumping
duties by the amount of antidumping
duties reimbursed.
Administrative Protective Orders
This notice also serves as a reminder
to parties subject to administrative
protective orders (APOs) of their
responsibility concerning the return or
destruction of proprietary information
disclosed under APO in accordance
with 19 CFR 351.305(a)(3). Timely
written notification of the return/
destruction of APO materials or
conversion to judicial protective order is
hereby requested. Failure to comply
with the regulations and terms of an
APO is a violation that is subject to
sanction.
We are issuing and publishing these
results and notice in accordance with
sections 751(a)(1) and 777(i)(1) of the
Act.
Dated: November 1, 2007.
David M. Spooner,
Assistant Secretary for Import
Administration.
[FR Doc. E7–21871 Filed 11–6–07; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
International Trade Administration
[A–533–845]
Notice of Amended Preliminary
Determination of Sales at Less Than
Fair Value: Glycine From India
Import Administration,
International Trade Administration,
Department of Commerce.
DATES: Effective Date: November 7,
2007.
SUMMARY: The purpose of this amended
preliminary determination is to clarify
an inadvertent error in the preliminary
determination we issued on October 26,
2007, that imports of glycine from India
are being, or are likely to be, sold in the
United States at less than fair value, as
provided in section 733(b) of the Tariff
Act of 1930, as amended (the Act).
FOR FURTHER INFORMATION CONTACT:
George Callen or Richard Rimlinger,
AD/CVD Operations, Office 5, Import
Administration, International Trade
Administration, U.S. Department of
Commerce, 14th Street and Constitution
AGENCY:
Avenue, NW., Washington, DC 20230;
telephone: (202) 482–0180 and (202)
482–4477, respectively.
SUPPLEMENTARY INFORMATION:
Background
We initiated an antidumping
investigation on glycine from India. See
Glycine from India, Japan, and the
Republic of Korea: Initiation of
Antidumping Duty Investigations, 72 FR
20816 (April 26, 2007). On October 26,
2007, we issued our preliminary
determination of sales at less than fair
value (not yet published). We stated in
our October 26, 2007, preliminary
determination that we used total facts
available, including an adverse
inference, for one firm, Nutracare
International/Salvi Chemical Industries
(Salvi), which did not respond to our
quantity and value (Q&V) questionnaire
and, therefore, withheld requested
information and significantly impeded
this proceeding pursuant to section
776(a) of the Act. We stated further that,
because it did not cooperate by not
acting to the best of its ability, in
reaching our preliminary determination
we applied total adverse facts available
to Salvi pursuant to section 776(b) of the
Act.
There were nine firms in addition to
Salvi which did not respond to our Q&V
questionnaire and, to clarify our
inadvertent error of omission of these
firms, we are amending our preliminary
determination. The firms which failed
to respond to our request for
information and for which we are
applying adverse facts available in
accordance with sections 776(a) and
776(b) of the Act are as follows:
Abhiyan Media Pvt. Ltd., Ashok AlcoChem, Ltd., Bimal Pharma, Pvt., Ltd.,
Euro Asian Industrial Co., EPIC
Enzymes Pharmaceuticals & Industrial,
Indian Chemical Industries, Kumar
Industries, Sisco Research Laboratories
Pvt. Ltd, and Sealink International, Inc.
Amended Preliminary Determination
We preliminarily determine that the
following weighted-average dumping
margins exist for the period January 1,
2006, through December 31, 2006:
Weighted-average
margin (percent)
pwalker on PROD1PC71 with NOTICES
Manufacturer/exporter
Paras Intermediates Ltd. ...........................................................................................................................................................
Abhiyan Media Pvt. Ltd. ............................................................................................................................................................
Advanced Exports/Aico Laboratories ........................................................................................................................................
Ashok Alco-Chem, Ltd. ..............................................................................................................................................................
Bimal Pharma, Pvt., Ltd. ............................................................................................................................................................
Euro Asian Industrial Co. ...........................................................................................................................................................
EPIC Enzymes Pharmaceuticals & Industrial ...........................................................................................................................
Indian Chemical Industries ........................................................................................................................................................
Kumar Industries ........................................................................................................................................................................
VerDate Aug<31>2005
16:14 Nov 06, 2007
Jkt 214001
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
E:\FR\FM\07NON1.SGM
07NON1
0.00
121.62
121.62
121.62
121.62
121.62
121.62
121.62
121.62
Federal Register / Vol. 72, No. 215 / Wednesday, November 7, 2007 / Notices
Weighted-average
margin (percent)
Manufacturer/exporter
Nutracare International/Salvi Chemical Industries ....................................................................................................................
Sisco Research Laboratories Pvt. Ltd. ......................................................................................................................................
Sealink International, Inc. ..........................................................................................................................................................
All Others ...................................................................................................................................................................................
Suspension of Liquidation
In accordance with section 733(d) of
the Act, we will instruct U.S. Customs
and Border Protection (CBP) to suspend
liquidation of all entries of glycine from
India that are entered, or withdrawn
from warehouse, for consumption on or
after the date of publication of this
notice in the Federal Register. We will
instruct CBP to require a cash deposit or
the posting of a bond equal to the
weighted-average margin, as indicated
in the chart above, as follows: (1) The
rates for the mandatory respondents
except Paras will be the rates we have
determined in this preliminary
determination; (2) if the exporter is not
a firm identified in this investigation
but the producer is, the rate will be the
rate established for the producer of the
subject merchandise; (3) the rate for all
other producers or exporters will be
45.82 percent. These suspension-ofliquidation instructions will remain in
effect until further notice.
In accordance with 19 CFR
351.204(e)(2), because the weightedaverage margin for Paras is zero, we will
not instruct CBP to suspend liquidation
of merchandise produced and exported
by Paras.
pwalker on PROD1PC71 with NOTICES
International Trade Commission
Notification
In accordance with section 733(f) of
the Act, we have notified the ITC of our
amended preliminary determination of
sales at less than fair value. If our final
antidumping determination is
affirmative, the ITC will determine
whether the imports covered by that
determination are materially injuring, or
threatening material injury to, the U.S.
industry. The deadline for the ITC’s
determination would be the later of 120
days after the date of the preliminary
determination or 45 days after the date
of our final determination.
Public Comment
Interested parties are invited to
comment on the amended preliminary
determination. Interested parties may
submit case briefs to the Department no
later than seven days after the date of
the issuance of the final verification
report in this proceeding. Rebuttal
briefs, the content of which is limited to
the issues raised in the case briefs, must
be filed within five days from the
VerDate Aug<31>2005
16:14 Nov 06, 2007
Jkt 214001
deadline for the submission of case
briefs. Executive summaries should be
limited to five pages total, including
footnotes. Further, we request that
parties submitting briefs and rebuttal
briefs provide us with a copy of the
public version of such briefs on diskette.
Section 774 of the Act provides that
the Department will hold a hearing to
afford interested parties an opportunity
to comment on arguments raised in case
or rebuttal briefs, provided that such a
hearing is requested by an interested
party. If a request for a hearing is made
in this investigation, the hearing
normally will be held two days after the
deadline for submission of the rebuttal
briefs at the U.S. Department of
Commerce, 14th Street and Constitution
Avenue, NW., Washington, DC 20230.
Parties should confirm by telephone the
time, date, and place of the hearing 48
hours before the scheduled time.
Interested parties who wish to request a
hearing, or to participate if one is
requested, must submit a written
request within 30 days of the
publication of this notice. Requests
should specify the number of
participants and provide a list of the
issues to be discussed. Oral
presentations will be limited to issues
raised in the briefs. We will make our
final determination within 75 days after
the date of the preliminary
determination.
This determination is issued and
published pursuant to sections 733(f)
and 777(i)(1) of the Act.
Dated: November 1, 2007.
David M. Spooner,
Assistant Secretary for Import
Administration.
[FR Doc. E7–21872 Filed 11–6–07; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
International Trade Administration
[A–533–845]
Notice of Preliminary Determination of
Sales at Less Than Fair Value: Glycine
From India
Import Administration,
International Trade Administration,
Department of Commerce.
AGENCY:
PO 00000
Frm 00016
Fmt 4703
62827
Sfmt 4703
DATES:
121.62
121.62
121.62
45.82
Effective Dates: November 7,
2007.
SUMMARY: We preliminarily determine
that imports of glycine from India are
being, or are likely to be, sold in the
United States at less than fair value, as
provided in section 733(b) of the Tariff
Act of 1930, as amended (the Act).
Interested parties are invited to
comment on this preliminary
determination. We will make our final
determination within 75 days after the
date of this preliminary determination.
FOR FURTHER INFORMATION CONTACT:
George Callen or Kristin Case, AD/CVD
Operations, Office 5, Import
Administration, International Trade
Administration, U.S. Department of
Commerce, 14th Street and Constitution
Avenue, NW., Washington, DC 20230;
telephone: (202) 482–0180 and (202)
482–3174, respectively.
SUPPLEMENTARY INFORMATION:
Background
On April 26, 2007, the Department of
Commerce (the Department) published
in the Federal Register the initiation of
an antidumping investigation on glycine
from India. See Glycine from India,
Japan, and the Republic of Korea:
Initiation of Antidumping Duty
Investigations, 72 FR 20816 (April 26,
2007) (Initiation Notice). The
Department set aside a period for all
interested parties to raise issues
regarding product coverage. See
Initiation Notice, 72 FR at 20817. We
did not receive comments regarding
product coverage from any interested
party.
On May 17, 2007, we issued the
quantity-and-value (Q&V) questionnaire
to all companies identified in the
petition. In addition, we issued the Q&V
questionnaire to companies in India for
which we obtained public information
indicating that the companies produced
and/or exported glycine or
pharmaceuticals. See the June 22, 2007,
Memorandum to the File entitled
‘‘Issuance of Quantity and Value
Questionnaires to Potential Indian
Respondents.’’ We received responses
from seven companies. Based on an
analysis of U.S. Customs and Border
Protection (CBP) import statistics of
Indian glycine under the Harmonized
Tariff Schedule of the United States
(HTSUS) number 2922.49.4020,
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 72, Number 215 (Wednesday, November 7, 2007)]
[Notices]
[Pages 62826-62827]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-21872]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
[A-533-845]
Notice of Amended Preliminary Determination of Sales at Less Than
Fair Value: Glycine From India
AGENCY: Import Administration, International Trade Administration,
Department of Commerce.
DATES: Effective Date: November 7, 2007.
SUMMARY: The purpose of this amended preliminary determination is to
clarify an inadvertent error in the preliminary determination we issued
on October 26, 2007, that imports of glycine from India are being, or
are likely to be, sold in the United States at less than fair value, as
provided in section 733(b) of the Tariff Act of 1930, as amended (the
Act).
FOR FURTHER INFORMATION CONTACT: George Callen or Richard Rimlinger,
AD/CVD Operations, Office 5, Import Administration, International Trade
Administration, U.S. Department of Commerce, 14th Street and
Constitution Avenue, NW., Washington, DC 20230; telephone: (202) 482-
0180 and (202) 482-4477, respectively.
SUPPLEMENTARY INFORMATION:
Background
We initiated an antidumping investigation on glycine from India.
See Glycine from India, Japan, and the Republic of Korea: Initiation of
Antidumping Duty Investigations, 72 FR 20816 (April 26, 2007). On
October 26, 2007, we issued our preliminary determination of sales at
less than fair value (not yet published). We stated in our October 26,
2007, preliminary determination that we used total facts available,
including an adverse inference, for one firm, Nutracare International/
Salvi Chemical Industries (Salvi), which did not respond to our
quantity and value (Q&V) questionnaire and, therefore, withheld
requested information and significantly impeded this proceeding
pursuant to section 776(a) of the Act. We stated further that, because
it did not cooperate by not acting to the best of its ability, in
reaching our preliminary determination we applied total adverse facts
available to Salvi pursuant to section 776(b) of the Act.
There were nine firms in addition to Salvi which did not respond to
our Q&V questionnaire and, to clarify our inadvertent error of omission
of these firms, we are amending our preliminary determination. The
firms which failed to respond to our request for information and for
which we are applying adverse facts available in accordance with
sections 776(a) and 776(b) of the Act are as follows: Abhiyan Media
Pvt. Ltd., Ashok Alco-Chem, Ltd., Bimal Pharma, Pvt., Ltd., Euro Asian
Industrial Co., EPIC Enzymes Pharmaceuticals & Industrial, Indian
Chemical Industries, Kumar Industries, Sisco Research Laboratories Pvt.
Ltd, and Sealink International, Inc.
Amended Preliminary Determination
We preliminarily determine that the following weighted-average
dumping margins exist for the period January 1, 2006, through December
31, 2006:
------------------------------------------------------------------------
Weighted-average
Manufacturer/exporter margin (percent)
------------------------------------------------------------------------
Paras Intermediates Ltd............................ 0.00
Abhiyan Media Pvt. Ltd............................. 121.62
Advanced Exports/Aico Laboratories................. 121.62
Ashok Alco-Chem, Ltd............................... 121.62
Bimal Pharma, Pvt., Ltd............................ 121.62
Euro Asian Industrial Co........................... 121.62
EPIC Enzymes Pharmaceuticals & Industrial.......... 121.62
Indian Chemical Industries......................... 121.62
Kumar Industries................................... 121.62
[[Page 62827]]
Nutracare International/Salvi Chemical Industries.. 121.62
Sisco Research Laboratories Pvt. Ltd............... 121.62
Sealink International, Inc......................... 121.62
All Others......................................... 45.82
------------------------------------------------------------------------
Suspension of Liquidation
In accordance with section 733(d) of the Act, we will instruct U.S.
Customs and Border Protection (CBP) to suspend liquidation of all
entries of glycine from India that are entered, or withdrawn from
warehouse, for consumption on or after the date of publication of this
notice in the Federal Register. We will instruct CBP to require a cash
deposit or the posting of a bond equal to the weighted-average margin,
as indicated in the chart above, as follows: (1) The rates for the
mandatory respondents except Paras will be the rates we have determined
in this preliminary determination; (2) if the exporter is not a firm
identified in this investigation but the producer is, the rate will be
the rate established for the producer of the subject merchandise; (3)
the rate for all other producers or exporters will be 45.82 percent.
These suspension-of-liquidation instructions will remain in effect
until further notice.
In accordance with 19 CFR 351.204(e)(2), because the weighted-
average margin for Paras is zero, we will not instruct CBP to suspend
liquidation of merchandise produced and exported by Paras.
International Trade Commission Notification
In accordance with section 733(f) of the Act, we have notified the
ITC of our amended preliminary determination of sales at less than fair
value. If our final antidumping determination is affirmative, the ITC
will determine whether the imports covered by that determination are
materially injuring, or threatening material injury to, the U.S.
industry. The deadline for the ITC's determination would be the later
of 120 days after the date of the preliminary determination or 45 days
after the date of our final determination.
Public Comment
Interested parties are invited to comment on the amended
preliminary determination. Interested parties may submit case briefs to
the Department no later than seven days after the date of the issuance
of the final verification report in this proceeding. Rebuttal briefs,
the content of which is limited to the issues raised in the case
briefs, must be filed within five days from the deadline for the
submission of case briefs. Executive summaries should be limited to
five pages total, including footnotes. Further, we request that parties
submitting briefs and rebuttal briefs provide us with a copy of the
public version of such briefs on diskette.
Section 774 of the Act provides that the Department will hold a
hearing to afford interested parties an opportunity to comment on
arguments raised in case or rebuttal briefs, provided that such a
hearing is requested by an interested party. If a request for a hearing
is made in this investigation, the hearing normally will be held two
days after the deadline for submission of the rebuttal briefs at the
U.S. Department of Commerce, 14th Street and Constitution Avenue, NW.,
Washington, DC 20230. Parties should confirm by telephone the time,
date, and place of the hearing 48 hours before the scheduled time.
Interested parties who wish to request a hearing, or to participate if
one is requested, must submit a written request within 30 days of the
publication of this notice. Requests should specify the number of
participants and provide a list of the issues to be discussed. Oral
presentations will be limited to issues raised in the briefs. We will
make our final determination within 75 days after the date of the
preliminary determination.
This determination is issued and published pursuant to sections
733(f) and 777(i)(1) of the Act.
Dated: November 1, 2007.
David M. Spooner,
Assistant Secretary for Import Administration.
[FR Doc. E7-21872 Filed 11-6-07; 8:45 am]
BILLING CODE 3510-DS-P
